Evaluation of Epidemiological and Clinical Features of Melasma Patients
PDF
Cite
Share
Request
Research Article
P: 220-226
September 2023

Evaluation of Epidemiological and Clinical Features of Melasma Patients

J Ankara Univ Fac Med 2023;76(3):220-226
1. Serbest Hekim, Ankara, Türkiye
2. Atılım Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Ankara, Türkiye
No information available.
No information available
Received Date: 22.03.2023
Accepted Date: 09.08.2023
Publish Date: 24.10.2023
PDF
Cite
Share
Request

ABSTRACT

Objectives:

Melasma is an acquired pigmentation disorder characterized by hyperpigmented lesions most commonly located in the face area. Although the etiology is not fully known; genetic factors, ultraviolet exposure, oral contraceptive pills (OCPs), hormones, pregnancy, drug use, cosmetic products, endocrinological diseases, and psychological factors can trigger. In our study, it was aimed to investigate the epidemiological characteristics of patients diagnosed with melasma and to contribute to the data in our country.

Methods:

The data of patients who applied to the dermatology clinic between 2013-2021 and were diagnosed with melasma were retrospectively analyzed. Age, sex, Fitzpatrick skin type, clinical type of melasma, sunscreen use, pregnancy, OCP use, other drug use, and family history of the patients were examined. In addition, the results of free T3 and T4, TSH, and thyroid autoantibodies were recorded. SPSS 26 (Statistical Package for the Social Sciences) program was used for statistical analysis.

Results:

Two hundred and ninety-three patients were included in the study and their mean age was 37.17±7.97 years, all of whom were female. 4.4% of the patients had skin type II, 51.2% had skin type III and 44% had skin type IV. Melasma was 48.5% malar, 45.1% centrofacial and 3.8% mandibular type. Pregnancy was detected in 34.5%, family history in 17.4%, and OCP use in 13% of the cases. In cases triggered by pregnancy, malar, and mandibular type were significantly higher, while the centrofacial type rate was significantly lower (p<0.05). The rate of using sunscreen was higher in patients with skin type II (p<0.05).

Conclusion:

Melasma is a pigmentation disorder that most commonly develops due to pregnancy, ultraviolet exposure, and OCP use and is more common in women. Although sun protection is effective in preventing the disease, very few patients apply sunscreen regularly.

Keywords: Melasma, Etiology, Clinical Features

References

1
Doolan BJ, Gupta M. Melasma. Aust J Gen Pract. 2021;50:880-885.
2
Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89:771-782.
3
Majid I, Aleem S. Melasma: Update on Epidemiology, Clinical Presentation, Assessment, and Scoring. J Skin Stem Cell. 2021;8:e120283.
4
Balık Z, Balık A, Yüksel S, et al. Evaluation of Demographic Features, Clinical Characteristics and Quality of Life in Melasma Patients as Compared to the Control Group. Turkiye Klinikleri J Dermatol. 2020;30:81-87.
5
Ozdemir S, Ozdemir M. Melasma in Pregnancy. Turkderm-Turk Arch Dermatol Venereol. 2006;40:98-100.
6
Çakmak SK, Özcan N, Kılıç A, et al. Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients. Postepy Dermatol Alergol. 2015;32:327-330.
7
Tzouveka E. Epidemiology and Risk Factors of Melasma. J Pigment Disord. 2014:1;1-3.
8
Sarkar R, Jain RK, Puri P. Melasma in Indian males. Dermatol Surg. 2003;29:204.
9
Tamega Ade A, Miot LD, Bonfietti C, et al. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27:151-156.
10
Guinot C, Cheffai S, Latreille J, et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol. 2010;24:1060-1069.
11
Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011;56:380-382.
12
Sarkar R, Jagadeesan S, Basavapura Madegowda S, et al. Clinical and epidemiologic features of melasma: a multicentric cross-sectional study from India. Int J Dermatol. 2019;58:1305-1310.
13
Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455-458.
14
Hexsel D, Lacerda DA, Cavalcante AS, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014;53:440-444.
15
Handel AC, Lima PB, Tonolli VM, et al. Risk factors for facial melasma in women: a case-control study. Br J Dermatol. 2014;171:588-594.
16
Satish DA, Aparna AD, Radhika VK. A clinico-epidemiological study of melasma in 402 patients in an office-based practice. Clin Dermatol Rev. 2019;3:154-156.
17
Lakhdar H, Zouhair K, Khadir K, et al. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol. 2007;21:738-742.
18
Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72:189-190.
19
KrupaShankar DS, Somani VK, Kohli M, et al. A cross-sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther (Heidelb). 2014;4:71-81.
20
Lutfi RJ, Fridmanis M, Misiunas AL, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985;61:28-31.
21
Yazdanfar A, Hashemi B. Association of melasma with thyroid autoimmunity: a case-control study. Iran J Dermatol. 2010;13:51-53.
22
Kheradmand M, Afshari M, Damiani G, et al. Melasma and thyroid disorders: a systematic review and meta-analysis. Int J Dermatol. 2019;58:1231-1238.
23
Yazıcı AC, Baz K, İkizoğlu G, et al. The role of sex and thyroid hormones in the etiopathogenesis of melasma in men. Turkiye Klinikleri J Med Sci. 2006;26:240-244.
2024 ©️ Galenos Publishing House